ecrin-mdr-crcClinical2022Breast cancer, colorectal cancerBreast Cancer, Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/37173China3ECRIN MDRNot yet recruitingfalseEffect of rice bran arabinoxylan (MGN-3) on immune function in patients with breast and colorectal cancer: a prospective, open-label, single-arm clinical trialInterventions: Experimental group:MGN-3 Primary outcome(s): Change from baseline in patient NK cell levels Study Design: Single arm2022-03-1537173ChiCTR2200056886